These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 18365405

  • 1. De novo production of donor-specific anti-HLA alloantibodies in early acute humoral renal allograft rejection.
    Spriewald BM, Hugo C.
    Clin Transpl; 2006; ():469-72. PubMed ID: 18365405
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. De novo anti-HLA antibody responses after renal transplantation: detection and clinical impact.
    Seveso M, Bosio E, Ancona E, Cozzi E.
    Contrib Nephrol; 2009; 162():87-98. PubMed ID: 19001816
    [Abstract] [Full Text] [Related]

  • 4. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 5. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I, Deutsch MA, Kauke T, Beiras-Fernandez A, Schmoeckel M, Vicol C, Sodian R, Reichart B, Spannagl M, Ueberfuhr P.
    Exp Clin Transplant; 2008 Sep 20; 6(3):229-35. PubMed ID: 18954302
    [Abstract] [Full Text] [Related]

  • 6. [Antibody-mediated acute rejection].
    Lefaucheur C, Nochy D, Glotz D.
    Nephrol Ther; 2008 Oct 20; 4 Suppl 3():S188-91. PubMed ID: 19000885
    [Abstract] [Full Text] [Related]

  • 7. Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review.
    Kaczmarek I, Deutsch MA, Sadoni S, Brenner P, Schmauss D, Daebritz SH, Weiss M, Meiser BM, Reichart B.
    J Heart Lung Transplant; 2007 May 20; 26(5):511-5. PubMed ID: 17449422
    [Abstract] [Full Text] [Related]

  • 8. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N, Pirsch J, Samaniego M.
    Transplant Rev (Orlando); 2009 Jan 20; 23(1):34-46. PubMed ID: 19027615
    [Abstract] [Full Text] [Related]

  • 9. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
    Vlad G, Ho EK, Vasilescu ER, Colovai AI, Stokes MB, Markowitz GS, D'Agati VD, Cohen DJ, Ratner LE, Suciu-Foca N.
    Hum Immunol; 2009 Aug 20; 70(8):589-94. PubMed ID: 19375470
    [Abstract] [Full Text] [Related]

  • 10. Pre-formed donor-specific alloantibodies (DSA) detected only by luminex technology using HLA-coated microspheres and causing acute humoral rejection and kidney graft dysfunction.
    Muro M, Llorente S, Gónzalez-Soriano MJ, Minguela A, Gimeno L, Alvarez-López MR.
    Clin Transpl; 2006 Aug 20; ():379-83. PubMed ID: 18365392
    [Abstract] [Full Text] [Related]

  • 11. Failure of anti-CD20 monoclonal antibody therapy to prevent antibody-mediated rejection in three crossmatch-positive renal transplant recipients.
    Matignon M, Tagnaouti M, Audard V, Dahan K, Lang P, Grimbert P.
    Transplant Proc; 2007 Oct 20; 39(8):2565-7. PubMed ID: 17954175
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Post-transplantation anti-HLA antibodies: which relevance?].
    Glotz D.
    Nephrol Ther; 2008 Jun 20; 4 Suppl 1():S8-S12. PubMed ID: 18703400
    [Abstract] [Full Text] [Related]

  • 15. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.
    Cardarelli F, Pascual M, Tolkoff-Rubin N, Delmonico FL, Wong W, Schoenfeld DA, Zhang H, Cosimi AB, Saidman SL.
    Transpl Int; 2005 May 20; 18(5):532-40. PubMed ID: 15819801
    [Abstract] [Full Text] [Related]

  • 16. Alloantibodies and the outcome of cadaver kidney allografts.
    Vasilescu ER, Ho EK, Colovai AI, Vlad G, Foca-Rodi A, Markowitz GS, D'Agati V, Hardy MA, Ratner LE, Suciu-Foca N.
    Hum Immunol; 2006 Aug 20; 67(8):597-604. PubMed ID: 16916655
    [Abstract] [Full Text] [Related]

  • 17. Antibody-mediated rejection.
    Akalin E, Watschinger B.
    Semin Nephrol; 2007 Jul 20; 27(4):393-407. PubMed ID: 17616272
    [Abstract] [Full Text] [Related]

  • 18. Detailed examination of HLA antibody development on renal allograft failure and function.
    Zhu L, Lee PC, Everly MJ, Terasaki PI.
    Clin Transpl; 2008 Jul 20; ():171-87. PubMed ID: 19711514
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The histopathology of lung allograft dysfunction associated with the development of donor-specific HLA alloantibodies.
    Yousem SA, Zeevi A.
    Am J Surg Pathol; 2012 Jul 20; 36(7):987-92. PubMed ID: 22510758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.